Mayne Pharma | MYX - Interest Expense On Debt


Mayne Pharma reported AUD1.2M in Interest Expense on Debt for its fiscal semester ending in June of 2024.





Interest Expense On Debt Change Date
Ansell USD 20.6M 300K Dec/2025
Avita Medical AUD 1.25M 100K Jun/2025
Cochlear AUD 6.3M 3.65M Dec/2025
CSL USD 215M 111M Dec/2025
Healius AUD 32.8M 15.4M Dec/2024
Integral Diagnostics AUD 5.34M 6.08M Jun/2024
Medical Developments International AUD 18K 3K Jun/2025
Nanosonics AUD 779K 94K Jun/2025
Polynovo AUD 506K 130K Jun/2025
Ramsay Health Care AUD 300.6M 15.5M Dec/2025
ResMed USD 775K 886K Dec/2024
Sigma Healthcare AUD 7.97M 365K Jan/2024
Sonic Healthcare AUD 86.91M 43.94M Dec/2024
Telix Pharmaceuticals AUD 19.39M 11.77M Jun/2026